All HSJ Partners articles – Page 19
-
HSJ PartnersRecovering cancer services from covid will take all of us
This is paid-for content from our commercial partners. Find out more Delivering healthcare is complicated and one of the barriers to improving it has always been the very wide range of different organisations who have a role but don’t always work together smoothly. The pandemic ...
-
HSJ PartnersISO 27001 certification offers a secure choice for NHS organisation
This is paid-for content from our commercial partners. Find out more The global pandemic caused by covid-19 has taught us many things about the way we live and work. For NHS Greater Manchester Shared Services, it put into practice months of hard work and demonstrated ...
-
HSJ PartnersGene Therapy – will the NHS lead or follow?
In a four-part series, Bluebirdbio is exploring how the NHS can embrace the power of gene therapy as a treatment for rare diseases in the UK, including some of the systemic changes that will be needed. In this fourth and last column, Ross Selby, MRPharmS, Bluebirdbio UK’s Access, Value and ...
-
HSJ PartnersDeveloper S.106 contributions: The key to sustainable communities
This is paid-for content from our commercial partners. Find out more The shortage of housing across the UK is a well-known fact; residential development is needed, and fast, particularly in the current economic climate. However, it is vital to ensure that the impact of these ...
-
HSJ PartnersHow Devon used its Virtual Voices panel to stay in touch with local people during lockdown
Citizens panels can help health and care partnerships to better understand residents’ experience and aspirations, by Dame Suzi Leather
-
HSJ PartnersWhy remote monitoring should be the focus of digital innovation
This is paid-for content from our commercial partners. Find out more When it comes to digital innovation in primary care, video calls have become the hot topic. However, there is a huge segment of patients who would benefit from more advanced digital practices, such ...
-
HSJ PartnersThe long road to purging the pager
Dr Jonathan Bloor argues that clinical value is the key to adoption of emerging tech
-
HSJ PartnersMaximising the potential of virtual care to better serve patients
Nicole Allan on how virtual care can improve healthcare outcomes for patients
-
HSJ PartnersRemembering sacrifices made by NHS emergency services personnel
Copyright: Tom Scholes Fogg The covid-19 pandemic, has galvanised the public’s understanding of the immediate and increasing sacrifices that our NHS and emergency services personnel, key workers and volunteers are making to keep us safe from harm. Written by This year the National Emergency Services Memorial ...
-
HSJ PartnersValuing young lives
In a four-part series, Bluebirdbio is exploring how the NHS can embrace the power of gene therapy as a treatment for rare diseases in the UK, including some of the systemic changes that will be needed. In this third column, David Taylor, emeritus professor of Pharmaceutical and Public Health Policy ...
-
HSJ PartnersWe need to hear the voices of healthcare professionals on how we change the ABPI Code of Practice
The Association of the British Pharmaceutical Industry is consulting on its proposed Code of Practice for 2021, which supports industry to operate in a professional, ethical and transparent manner. ABPI president Haseeb Ahmad explains how healthcare professionals come into contact with the Code, so it is important to contribute their ...
-
HSJ PartnersA bright future for genomics and gene therapy in the UK
In a four-part series, bluebird bio is exploring how the NHS can embrace the power of gene therapy as a treatment for rare diseases in the UK, including some of the systemic changes that will be needed. In this second column, Jonathan Appleby, the Cell and Gene Therapy Catapult’s chief ...
-
HSJ PartnersThe NHS IT challenge is not to go ‘paperless’ but to unlock the value of information
Paper records and other forms of unstructured data contain hugely valuable information. Trusts should be planning to capture and use it to meet covid and ‘reset’ challenges by deploying a modern electronic document management system, says Mike Seel
-
HSJ PartnersWe are all in the same storm, but we are not all in the same boat
It is more vital than ever that mental health services are not forgotten, but rather included at the forefront of the national response towards the pandemic, writes Asha Patel
-
HSJ Partners2020: The healthcare revolution with patients at the centre
Livi’s new model NHS 2.0 aims to deliver seamless, tech-enabled care with patients at the centre, creating one digital front door.
-
HSJ PartnersHow AI is easing the mounting pressures on GPs and hospitals?
AI-powered solutions are helping GPs effectively implement pathway guidance and reduce unnecessary referrals to hospitals, writes David Ezra
-
HSJ PartnersCovid-19 poses a new challenge for point-of-care manufacturing
The spread of covid-19 outbreaks has led facilities in medical device manufacturing to rigorously anticipate, plan, and innovate. By Ali Burns, managing director of Siemens Healthineers Sudbury, UK manufacturing facility.
-
HSJ PartnersSupporting black leaders to fulfil their potential
Kate Wilson from Korn Ferry explores the experiences that are siphoning many black leaders from the leadership pipeline and the steps that leaders must take to advance black talent from entry level to the top
-
HSJ PartnersImproving mental health with digital CBT: bridging the treatment gap for insomnia
In its efforts to address insomnia and improve mental health, the NHS is grappling with long-standing challenges that leave millions every year without access to therapy. Sleepio’s digital CBT for insomnia offers an intervention that is safe, effective, and scalable – and now proven to offer multimillion pound cost reductions ...
-
HSJ PartnersRestoring health by embracing the transformative potential of gene therapy
In a four-part series, bluebird bio is exploring how the NHS can embrace the power of gene therapy as a treatment for rare diseases in the UK, including some of the systemic changes that will be needed. Here in the first column, Nicola Redfern, bluebird bio UK’s General Manager, discusses ...